These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20215124)

  • 21. Chronic plaque psoriasis is associated with increased arterial stiffness.
    Gisondi P; Fantin F; Del Giglio M; Valbusa F; Marino F; Zamboni M; Girolomoni G
    Dermatology; 2009; 218(2):110-3. PubMed ID: 19060461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research in practice: the systemic aspects of psoriasis.
    Boehncke WH; Boehncke S
    J Dtsch Dermatol Ges; 2008 Aug; 6(8):622-5. PubMed ID: 18564207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriasis and Cardiovascular Risk: A Comprehensive Review.
    Masson W; Lobo M; Molinero G
    Adv Ther; 2020 May; 37(5):2017-2033. PubMed ID: 32314303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
    Gisondi P; Girolomoni G
    Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
    Jurcuţ C; Jurcuţ R; Tănăsescu C
    Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AJC editor's consensus: psoriasis and coronary artery disease.
    Friedewald VE; Cather JC; Gelfand JM; Gordon KB; Gibbons GH; Grundy SM; Jarratt MT; Krueger JG; Ridker PM; Stone N; Roberts WC
    Am J Cardiol; 2008 Dec; 102(12):1631-43. PubMed ID: 19064017
    [No Abstract]   [Full Text] [Related]  

  • 27. Psoriasis and vascular disease: an unsolved mystery.
    Shelling ML; Federman DG; Prodanovich S; Kirsner RS
    Am J Med; 2008 May; 121(5):360-5. PubMed ID: 18456026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.
    Sterry W; Strober BE; Menter A;
    Br J Dermatol; 2007 Oct; 157(4):649-55. PubMed ID: 17627791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On cardiovascular risk estimation in patients with psoriasis: The REGICOR and SCORE scales.
    Labandeira García J; Alonso-González J
    Actas Dermosifiliogr; 2012 Dec; 103(10):942-3; discussion 943-4. PubMed ID: 23149054
    [No Abstract]   [Full Text] [Related]  

  • 31. Biomarkers, atherosclerosis and cardiovascular events.
    Rosenson RS
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):619-22. PubMed ID: 18510479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying the vulnerable patient with rupture-prone plaque.
    Weintraub HS
    Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality.
    Wong TY; McIntosh R
    Br Med Bull; 2005; 73-74():57-70. PubMed ID: 16148191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriasis: cardiovascular risk factors and other disease comorbidities.
    Wu Y; Mills D; Bala M
    J Drugs Dermatol; 2008 Apr; 7(4):373-7. PubMed ID: 18459519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasis: an opportunity to identify cardiovascular risk.
    Tobin AM; Kirby B
    Br J Dermatol; 2009 Sep; 161(3):719. PubMed ID: 19614648
    [No Abstract]   [Full Text] [Related]  

  • 36. [Severe psoriasis: beyond the skin, what are the risks of not treating the disease?].
    Bessis D
    Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S285-9. PubMed ID: 18721666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular morbidity, risk of cancer and alcohol abuse in psoriasis: systematic literature reviews and expert opinion.
    Richard MA; Paul C
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():1. PubMed ID: 23845147
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular aspects of psoriasis: an updated review.
    Ahlehoff O; Gislason G; Hansen PR
    Int J Dermatol; 2014 Jun; 53(6):e337. PubMed ID: 24673198
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk charts--very popular but useless?
    Sinzinger H; Derfler K; Laimer H; Seyfried H; Maier M
    Vasa; 2010 Nov; 39(4):287-9. PubMed ID: 21186690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.